Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, beat all records for the show, attracting 3,113 attendees - a 10% increase on the previous year. Underlying the headline number were significant increases in visitors involved in purchasing products and services. Overall, 79% of visitors were involved in the purchasing decision, with a 43% increase in lab managers, a 53% increase in lab technicians, and an impressive 125% increase in procurement managers. In addition, the number of scientists attending increased by 49%...

Thermo Scientific Mass Frontier 8.0 software with Thermo Scientific Orbitrap ID-X Tribrid Mass Spectrometer streamlines small-molecule unknown compound identification and structural elucidation. Pharmaceutical scientists are now able to overcome challenges associated with the identification and characterization of small molecules and their fragments with Thermo Scientific Mass Frontier 8.0 software, which quickly translates complex data into actionable, sharable knowledge...

Scotland is to have its own £15.8m artificial intelligence health research centre, which promises to enable better patient diagnosis, treatment and outcomes. The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, to be known as iCAIRD, brings together a pan-Scotland collaboration of 15 partners from across academia, the NHS, and industry. Greg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), announced that UK Research and Innovation will invest £10million in iCAIRD...

Oxford HighQ, a spinout from Oxford University, aims to revolutionise chemical and nanoparticle sensor technology with ‘quantum’ sensors up to 10,000 times more sensitive than current counterparts. Oxford HighQ, a quantum technologies spinout from Oxford University, has launched with £2.1m in seed funding to commercialise components of quantum computing technology developed at the University, providing a step change in performance for chemical and nanoparticle sensing....

BioAscent’s COO, Sylviane Boucharens named in top 50 Movers and Shakers in BioBusiness. BioAscent Discovery Limited’s COO, Dr Sylviane Boucharens, has been included in the BioBeat 2018 list of 50 Movers and Shakers in BioBusiness. Her nomination follows an incredibly successful year in which she has spearheaded the company’s expansion to become a fully integrated drug discovery CRO. Co-founded by Dr Boucharens in 2013, BioAscent initially focused on compound management....